Structure-activity relationships involving the catechol subunit of rolipram
- 1 August 1994
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 4 (15) , 1855-1860
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Crystal structure, absolute configuration, and phosphodiesterase inhibitory activity of (+)-1-(4-bromobenzyl)-4-[(3-cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinoneJournal of Medicinal Chemistry, 1993
- The selective inhibition of phosphodiesterase IV by benzopyran derivatives of rolipramBioorganic & Medicinal Chemistry Letters, 1993
- Coexpression of human cAMP-specific phosphodiesterase activity and high affinity rolipram binding in yeast.Journal of Biological Chemistry, 1992
- Construction of polycyclic compounds by cyclocarbonylation. 6. Palladium-catalyzed cyclocarbonylation of 3-(heteroaryl)allyl acetatesThe Journal of Organic Chemistry, 1991
- Effects of novel catechol ether imidazolidinones on calcium‐independent phosphodiesterase activity, [3H]rolipram binding, and reserpine‐induced hypothermia in miceDrug Development Research, 1990
- Inhibition of cyclic adenosine-3',5'-monophosphate phosphodiesterase from vascular smooth muscle by rolipram analogsJournal of Medicinal Chemistry, 1989
- Synthesis of diarylic compounds by palladium catalyzed reaction of aromatic triflates with boronic acidsTetrahedron, 1989
- 4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62711): a Potent Inhibitor of Adenosine Cyclic 3',5'-Monophosphate Phosphodiesterases in Homogenates and Tissue Slices from Rat BrainMolecular Pharmacology, 1976